Next Article in Journal
Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases
Previous Article in Journal
ZNF714 Supports Pro-Oncogenic Features in Lung Cancer Cells
Previous Article in Special Issue
Step-by-Step Double-Trouble OBAIRH and DMD Diagnosis in a One-Year-Old Boy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient

by
Tatyana A. Vasilyeva
,
Natella V. Sukhanova
,
Andrey V. Marakhonov
*,
Natalia Yu. Kuzina
,
Nadezhda V. Shilova
,
Vitaly V. Kadyshev
,
Sergey I. Kutsev
and
Rena A. Zinchenko
Research Centre for Medical Genetics, 115522 Moscow, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(21), 15527; https://doi.org/10.3390/ijms242115527
Submission received: 27 September 2023 / Revised: 17 October 2023 / Accepted: 19 October 2023 / Published: 24 October 2023

Abstract

This study aims to present a clinical case involving the unique co-occurrence of congenital aniridia and Down syndrome in a young girl and to analyze the combined impact of these conditions on the patient’s phenotype. The investigation involved comprehensive pediatric and ophthalmological examinations alongside karyotyping and Sanger sequencing of the PAX6 gene. The patient exhibited distinctive features associated with both congenital aniridia and Down syndrome, suggesting a potential exacerbation of their effects. Cytogenetic and molecular genetic analysis revealed the presence of trisomy 21 and a known pathogenic nonsense variant in exon 6 of the PAX6 gene (c.282C>A, p.(Cys94*)) corresponding to the paired domain of the protein. The observation of these two hereditary anomalies offers valuable insights into the molecular pathogenetic mechanisms underlying each condition. Additionally, it provides a basis for a more nuanced prognosis of the complex disease course in this patient. This case underscores the importance of considering interactions between different genetic disorders in clinical assessments and treatment planning.
Keywords: rare diseases; co-occurrence; complex phenotype; PAX6 nonsense variant; congenital aniridia; trisomy 21; Down syndrome rare diseases; co-occurrence; complex phenotype; PAX6 nonsense variant; congenital aniridia; trisomy 21; Down syndrome

Share and Cite

MDPI and ACS Style

Vasilyeva, T.A.; Sukhanova, N.V.; Marakhonov, A.V.; Kuzina, N.Y.; Shilova, N.V.; Kadyshev, V.V.; Kutsev, S.I.; Zinchenko, R.A. Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient. Int. J. Mol. Sci. 2023, 24, 15527. https://doi.org/10.3390/ijms242115527

AMA Style

Vasilyeva TA, Sukhanova NV, Marakhonov AV, Kuzina NY, Shilova NV, Kadyshev VV, Kutsev SI, Zinchenko RA. Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient. International Journal of Molecular Sciences. 2023; 24(21):15527. https://doi.org/10.3390/ijms242115527

Chicago/Turabian Style

Vasilyeva, Tatyana A., Natella V. Sukhanova, Andrey V. Marakhonov, Natalia Yu. Kuzina, Nadezhda V. Shilova, Vitaly V. Kadyshev, Sergey I. Kutsev, and Rena A. Zinchenko. 2023. "Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient" International Journal of Molecular Sciences 24, no. 21: 15527. https://doi.org/10.3390/ijms242115527

APA Style

Vasilyeva, T. A., Sukhanova, N. V., Marakhonov, A. V., Kuzina, N. Y., Shilova, N. V., Kadyshev, V. V., Kutsev, S. I., & Zinchenko, R. A. (2023). Co-Occurrence of Congenital Aniridia Due to Nonsense PAX6 Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient. International Journal of Molecular Sciences, 24(21), 15527. https://doi.org/10.3390/ijms242115527

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop